Monday, August 28, 2023 11:44:09 AM
https://ih.advfn.com/stock-market/NASDAQ/panbela-therapeutics-PBLA/stock-news/91905757/panbela-to-present-at-h-c-wainwright-25th-annual
" I can't complain , but sometimes I still do . "
Recent PBLA News
- Panbela Provides Business Update and Reports Q1 2024 Financial Results • GlobeNewswire Inc. • 05/15/2024 08:10:39 PM
- Panbela Announces Issuance of New Patent in the US and Canada; Patent is for Claims of a Fixed Dose Combination of Eflornithine and Sulindac • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Panbela to Host First Quarter 2024 Earnings Conference Call on May 15, 2024 • GlobeNewswire Inc. • 05/01/2024 08:15:00 PM
- Acceptance of Eflornithine (DFMO) Abstract for Oral Presentation at Digestive Disease Week • GlobeNewswire Inc. • 04/30/2024 12:00:00 PM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 04/26/2024 08:39:41 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/25/2024 08:36:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/25/2024 08:35:56 PM
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 04/25/2024 01:09:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/22/2024 12:02:00 PM
- Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025 • GlobeNewswire Inc. • 04/22/2024 12:00:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/18/2024 08:31:22 PM
- Panbela Announces Poster Presentation at American Association for Cancer Research: • GlobeNewswire Inc. • 04/18/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/17/2024 12:36:09 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/17/2024 04:15:36 AM
- Panbela Announces Transfer to OTCQB Market • GlobeNewswire Inc. • 04/16/2024 09:29:11 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/04/2024 08:17:05 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 03/29/2024 09:24:31 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 03/29/2024 09:08:13 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2024 08:15:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2024 08:12:27 PM
- Panbela Provides Business Update and Reports Q4 and FY 2024 Financial Results • GlobeNewswire Inc. • 03/26/2024 08:10:54 PM
- U.S. Index Futures on the Rise, Oil Prices Show Stability • IH Market News • 03/26/2024 11:21:42 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/25/2024 08:15:22 PM
- Panbela to Host Fourth Quarter and Year End 2023 Earnings Conference Call on March 26, 2024 • GlobeNewswire Inc. • 03/12/2024 08:15:00 PM
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM